Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma ProgressionLucia Casadei, Raphael E. Pollock, Kara Batte et al.|Cancer Research|2017Cited by 199
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J. Bill, Raphael E. Pollock, Jeannine Garnett et al.|Clinical Cancer Research|2015Cited by 106
Degree of <i>MDM2</i> Amplification Affects Clinical Outcomes in Dedifferentiated LiposarcomaKate Lynn J. Bill, James L. Chen|The Oncologist|2019Cited by 42